CELC
Celcuity Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website celcuity.com
- Employees(FY) 45
- ISIN US15102K1007
Performance
-3.4%
1W
-2.73%
1M
+9.97%
3M
+37.04%
6M
+15.03%
YTD
+67.18%
1Y
Profile
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Technical Analysis of CELC 2024-05-10
Overview:
In analyzing the technical indicators for CELC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Indicators...
Recent News & Updates
- 2024-05-16 11:54
- 2024-05-16 03:08
- 2024-05-15 18:04
Celcuity Q1 Net Loss Widens; Shares Rise After Hours(MT Newswires)
- 2024-05-15 16:01
- 2024-05-15 08:55
CELC Stock Earnings: Celcuity Beats EPS for Q1 2024(Investorplace)
- 2024-05-15 04:01
- 2024-05-08 07:05
- 2024-05-07 19:05
- 2024-05-03 00:15
- 2024-04-04 07:05
- 2024-04-03 19:05
- 2024-04-03 06:41
Celcuity Gains 12%, Insider Trades Reap Benefit(Simply Wall St.)
- 2024-04-01 13:38
Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript(Insider Monkey)
- 2024-04-01 01:38
Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript(Insidermonkey)
- 2024-03-27 18:51
Q4 2023 Celcuity Inc Earnings Call(Yahoo Finance)
- 2024-03-27 16:01
- 2024-03-27 08:53
CELC Stock Earnings: Celcuity Beats EPS for Q4 2023(Investorplace)
- 2024-03-27 05:51
- 2024-03-27 04:01
- 2024-03-21 11:17
- 2024-03-20 23:17
- 2024-03-20 07:05
- 2024-03-19 19:05
- 2024-03-06 07:05
- 2024-03-05 18:05
- 2024-02-28 07:05
- 2024-02-27 18:05
- 2024-02-22 16:05
- 2024-02-22 03:05
- 2024-02-20 07:05
Celcuity Appoints Eldon Mayer as Chief Commercial Officer(GlobeNewswire)
Page 1 of 5
previousnext